Exportin 1 Protein: Clinical Trials

2 trials of Exportin 1 Protein, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 unknown. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 1, Unknown 1
Phase 11Unknown 1

Follow Exportin 1 Protein: new trials by email Literature Review of Exportin 1 Protein trials Research Report on Exportin 1 Protein

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)
Selinexor Oral Tablet [Xpovio], R-CHOP Protocol - Diffuse Large B Cell Lymphoma
Phase 2RecruitingSun Yat-sen University422024-08-012026-02-12
Selinexor in Combination With R-CHOP Followed by Selinexor Maintenance for Untreated EBV-positive DLBCL Patients
Selinexor, R-CHOP Protocol - EBV-Positive Diffuse Large B-Cell Lymphoma, Nos
Phase 1 / Phase 2UnknownSun Yat-sen University542022-11-012023-12-14

Conditions studied

Lymphoma, Large B-Cell, Diffuse (1)  ·  Pyloric Stenosis, Hypertrophic (1)

Sponsors

Sun Yat-sen University (2)

Countries

China (2)

Top investigators

QingQing Cai, MD. PhD. (1)  ·  Rong Tao, MD. (1)  ·  Yi Xia, MD. PhD. (1)